Fitch Affirms PeaceHealth (WA) Rev Bonds at 'A+'; Stable Outlook

SAN FRANCISCO--()--Fitch Ratings has affirmed the 'A+' rating on PeaceHealth's outstanding debt, which is listed at the end of the press release.

The Rating Outlook is Stable.

SECURITY

The bonds are secured by a gross revenue pledge of the obligated group (OG). The OG accounted for 99% of total assets and 100% of total revenue of the consolidated entity in fiscal 2016 (June 30 year end). Fitch's analysis is based on the consolidated entity.

KEY RATING DRIVERS

GOOD MARKET POSITIONS: PeaceHealth's primary credit strength continues to be its geographic diversity and good market positions in its major service areas. The Northwest Network's (Bellingham, WA and Alaska) largest facility is St. Joseph Medical Center in Bellingham, WA, which has maintained over 80% market share the last four years. The Oregon West Network's (Eugene/Springfield/Florence, OR) flagship facility is Sacred Heart Riverbend and market share dropped to 67% from 70% the prior year due to physician and labor issues, which have been resolved and a rebound in market share is expected. The Columbia Network (Longview/Vancouver, WA) is the most challenging and competitive market with 49% market share.

GOOD LIQUIDITY: The rating affirmation also reflects PeaceHealth's solid balance sheet with total unrestricted cash and investments of $1.5 billion at Sept. 30, 2016, which equated to 242 days cash on hand and 146.7% cash to debt compared to the 'A' category medians of 215.5 days and 148.6% cash to debt.

PRESSURED PROFITABILITY: PeaceHealth has successfully implemented Epic (electronic health record), across its inpatient facilities (ambulatory was already complete) in all three networks which negatively impacted profitability especially in fiscal 2016. Operating EBITDA margin in fiscal 2016 fell to 7% from 13.5% in fiscal 2015 and 9.1% in fiscal 2014. However, Fitch notes that excluding Epic expenses operating EBITDA margin would have been 10.3% in fiscal 2016.

EXPECTED INCREASE IN CAPITAL SPENDING: Capital spending has been constrained but is expected to increase starting in fiscal 2018. The five year capital plan totals $1.5 billion (approximately 1.8x depreciation expense/year) which includes master facility needs, routine capital expenditures ($117 million a year), as well as strategic acute and ambulatory growth.

LIGHT DEBT SERVICE COVERAGE: Coverage of MADS weakened in fiscal 2016 to a light 2.5x from 4.0x and 3.5x in fiscal 2015 and 2014, respectively. Coverage was negatively impacted by Epic expenses and PeaceHealth's front loaded debt structure. The fiscal 2017 budget includes a 9.2% operating EBITDA margin (including Epic expenses) resulting in MADS coverage of 3.2x.

RATING SENSITIVITIES

FINANCIAL IMPROVEMENT EXPECTED: The rating affirmation reflects Fitch's expectation that operating cash flow will improve as a new management team implements its long range financial plan and realizes benefits of its favorable markets. The failure to meet the fiscal 2017 budget and ongoing operating EBITDA margin targets of around 10+% could trigger negative rating action.

ADDITIONAL DEBT PLANS: PeaceHealth has additional debt plans to fund a portion of its large capital plan within the next three years. Improved operating cash flow will be necessary to absorb additional debt at the current rating level.

CREDIT PROFILE

PeaceHealth is a multi-state health care system with 10 acute care hospitals (1,653 licensed beds) in Washington, Oregon, and Alaska with total revenue of $2.4 billion in fiscal 2016. PeaceHealth sold its interest in Columbia United Providers (Medicaid managed care lives) to Molina Health Care of Washington effective Dec. 31, 2015. The figures cited in this report are for the consolidated entity for the audited periods and obligated group for the interim financials.

At the time of the Fitch's last review in April 2015, the CEO and CFO positions were vacant and have been filled effective November 2015 and June 2016, respectively. In addition, governance was restructured from a traditional hospital board to a parent system board structure and half of the board members are new. There are ongoing management changes (COO role vacant) as well as personnel changes throughout the organization with a new culture focused on accountability.

GOOD MARKET POSITIONS

PeaceHealth's main credit strength is the system's geographic diversity and good market position in most of its service areas in Washington, Oregon and Alaska. Fitch views the revenue diversity favorably with the Oregon West Network accounting for 34.1% of consolidated revenue in fiscal 2016, Columbia Network with 28.9% and Northwest Network with 23.8%.

There was a disruption in the Oregon West Network in fiscal 2016 due to issues with the hospitalist group as well as labor pressures that resulted in diversions and impacted volume. These issues have been resolved and a rebound in volume is expected.

The Columbia Network continues to be the most challenging with two facilities in diverse markets and also the most competitive as it competes with the Portland metropolitan area. Issues have arisen in this Network since a Kaiser contract termination in October 2013. Fitch expects a longer-term strategy related to this Network by Fitch's next review since an evaluation of these strategies has been underway for some time with no marked progress, but likely slowed due to management changes.

PRESSURED PROFITABILITY

After several years of weaker operating performance, profitability rebounded in fiscal 2015 aided by one time items, and a trend of improved profitability would have been sustained without Epic implementation costs. The total cost of the inpatient electronic health record was budgeted at $293 million with $157 million expensed and $136 million capitalized. Operating expenses related to Epic totaled $126.4 million through Sept. 30, 2016 with the remainder to be spent by the second quarter of fiscal 2017. The implementation was successful with go live dates of May 1, 2016 for the Northwest Network, Aug. 1, 2016 for the Columbia Network, and Oct. 1, 2016 for the Oregon West Network.

Without the Epic costs, operating EBITDA margins have been over 10% compared to Fitch's 'A' category median of 10.3%. The fiscal 2017 budget is for a 9.2% operating EBITDA margin due to the remainder of the Epic costs (10.8% operating EBITDA margin without Epic). Fitch expects PeaceHealth to maintain close to or above 10% operating EBITDA margins.

The organization continues to invest in physician alignment and the employed physician group (PeaceHealth Medical Group) is at almost 700 FTEs. The losses at the Medical Group are fairly sizeable but the loss per provider has been declining.

INCREASE IN CAPITAL SPENDING

Capital spending is expected to increase significantly beginning in fiscal 2018. Capital expenditures are expected to total $302 million in fiscal 2018, $372 million in fiscal 2019, $337 million in fiscal 2020, $277 million in fiscal 2021, and $227 million in fiscal 2022.

There are growth and expansion plans included in the projections and the increased capital spending will need to be commensurate with improved, consistent financial performance.

DEBT PROFILE

Total master note debt is $990.2 million as of Sept. 30, 2016, which is 64% underlying fixed rate and 36% underlying variable rate. PeaceHealth's debt profile includes $502 million direct placements or bank loans and $146 million variable rate demand bonds. The direct placements and variable rate demand bonds have a three-year term out provision and the expiration dates and counterparty exposure are staggered and diversified, which is viewed favorably. Including the impact of its swaps, PeaceHealth's debt profile is 98% fixed rate. PeaceHealth is not posting any collateral related to its swaps.

MADS equals $88.5 million and occurs in fiscal 2017. The debt service schedule includes a smoothing of PeaceHealth's bullet maturities ($80.65 million in fiscal 2019 for series 2008A, $50 million in fiscal 2021 for US Bank loan and $130 million in fiscal 2024 for BofA loan) as permitted under the master trust indenture. Aggregate debt service is not level and MADS drops to $80.3 million in fiscal 2018 then $79.8 million post fiscal 2018.

PeaceHealth has a frozen defined benefit pension plan (legacy Southwest Medical Center plan) and the funded status dropped to 61% in fiscal 2016 from 74% the prior year due to a decline in the discount rate. Pension plan funding could pressure liquidity growth.

DISCLOSURE

PeaceHealth has covenanted to provide annual audited financial statements to Electronic Municipal Market Access within 150 days of each fiscal year end and unaudited quarterly financial statements (including a consolidated balance sheet, income statement, statement of cash flows, and utilization statistics) within 60 days of each fiscal quarter end.

Outstanding Debt:

--$66,060,000 Oregon Facilities Authority refunding revenue bonds (PeaceHealth Project), 2014 series A;

--$36,620,000 Washington Healthcare Facilities Authority refunding revenue bonds, series 2014A (PeaceHealth);

--$86,310,000 Oregon Facilities Authority (OR) (PeaceHealth) revenue bonds series 2009A;

--$72,410,000 Washington Health Care Facilities Authority (WA) (PeaceHealth) revenue bonds series 2009;

--$145,975,000 Oregon Facilities Authority (OR) (PeaceHealth) revenue bonds series 2008A&B (LOC: U.S. Bank National Association);

--$80,650,000 Washington Health Care Facilities Authority (WA) (PeaceHealth) revenue bonds series 2008A

Additional information is available at 'www.fitchratings.com'.

Applicable Criteria

Revenue-Supported Rating Criteria (pub. 16 Jun 2014)

https://www.fitchratings.com/site/re/750012

U.S. Nonprofit Hospitals and Health Systems Rating Criteria (pub. 09 Jun 2015)

https://www.fitchratings.com/site/re/866807

Additional Disclosures

Dodd-Frank Rating Information Disclosure Form

https://www.fitchratings.com/creditdesk/press_releases/content/ridf_frame.cfm?pr_id=1016332

Solicitation Status

https://www.fitchratings.com/gws/en/disclosure/solicitation?pr_id=1016332

Endorsement Policy

https://www.fitchratings.com/regulatory

ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTPS://WWW.FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY'S PUBLIC WEB SITE AT WWW.FITCHRATINGS.COM. PUBLISHED RATINGS, CRITERIA, AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE, AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE CODE OF CONDUCT SECTION OF THIS SITE. FITCH MAY HAVE PROVIDED ANOTHER PERMISSIBLE SERVICE TO THE RATED ENTITY OR ITS RELATED THIRD PARTIES. DETAILS OF THIS SERVICE FOR RATINGS FOR WHICH THE LEAD ANALYST IS BASED IN AN EU-REGISTERED ENTITY CAN BE FOUND ON THE ENTITY SUMMARY PAGE FOR THIS ISSUER ON THE FITCH WEBSITE.

Copyright © 2016 by Fitch Ratings, Inc., Fitch Ratings Ltd. and its subsidiaries. 33 Whitehall Street, NY, NY 10004. Telephone: 1-800-753-4824, (212) 908-0500. Fax: (212) 480-4435. Reproduction or retransmission in whole or in part is prohibited except by permission. All rights reserved. In issuing and maintaining its ratings and in making other reports (including forecast information), Fitch relies on factual information it receives from issuers and underwriters and from other sources Fitch believes to be credible. Fitch conducts a reasonable investigation of the factual information relied upon by it in accordance with its ratings methodology, and obtains reasonable verification of that information from independent sources, to the extent such sources are available for a given security or in a given jurisdiction. The manner of Fitch’s factual investigation and the scope of the third-party verification it obtains will vary depending on the nature of the rated security and its issuer, the requirements and practices in the jurisdiction in which the rated security is offered and sold and/or the issuer is located, the availability and nature of relevant public information, access to the management of the issuer and its advisers, the availability of pre-existing third-party verifications such as audit reports, agreed-upon procedures letters, appraisals, actuarial reports, engineering reports, legal opinions and other reports provided by third parties, the availability of independent and competent third-party verification sources with respect to the particular security or in the particular jurisdiction of the issuer, and a variety of other factors. Users of Fitch’s ratings and reports should understand that neither an enhanced factual investigation nor any third-party verification can ensure that all of the information Fitch relies on in connection with a rating or a report will be accurate and complete. Ultimately, the issuer and its advisers are responsible for the accuracy of the information they provide to Fitch and to the market in offering documents and other reports. In issuing its ratings and its reports, Fitch must rely on the work of experts, including independent auditors with respect to financial statements and attorneys with respect to legal and tax matters. Further, ratings and forecasts of financial and other information are inherently forward-looking and embody assumptions and predictions about future events that by their nature cannot be verified as facts. As a result, despite any verification of current facts, ratings and forecasts can be affected by future events or conditions that were not anticipated at the time a rating or forecast was issued or affirmed.

The information in this report is provided “as is” without any representation or warranty of any kind, and Fitch does not represent or warrant that the report or any of its contents will meet any of the requirements of a recipient of the report. A Fitch rating is an opinion as to the creditworthiness of a security. This opinion and reports made by Fitch are based on established criteria and methodologies that Fitch is continuously evaluating and updating. Therefore, ratings and reports are the collective work product of Fitch and no individual, or group of individuals, is solely responsible for a rating or a report. The rating does not address the risk of loss due to risks other than credit risk, unless such risk is specifically mentioned. Fitch is not engaged in the offer or sale of any security. All Fitch reports have shared authorship. Individuals identified in a Fitch report were involved in, but are not solely responsible for, the opinions stated therein. The individuals are named for contact purposes only. A report providing a Fitch rating is neither a prospectus nor a substitute for the information assembled, verified and presented to investors by the issuer and its agents in connection with the sale of the securities. Ratings may be changed or withdrawn at any time for any reason in the sole discretion of Fitch. Fitch does not provide investment advice of any sort. Ratings are not a recommendation to buy, sell, or hold any security. Ratings do not comment on the adequacy of market price, the suitability of any security for a particular investor, or the tax-exempt nature or taxability of payments made in respect to any security. Fitch receives fees from issuers, insurers, guarantors, other obligors, and underwriters for rating securities. Such fees generally vary from US$1,000 to US$750,000 (or the applicable currency equivalent) per issue. In certain cases, Fitch will rate all or a number of issues issued by a particular issuer, or insured or guaranteed by a particular insurer or guarantor, for a single annual fee. Such fees are expected to vary from US$10,000 to US$1,500,000 (or the applicable currency equivalent). The assignment, publication, or dissemination of a rating by Fitch shall not constitute a consent by Fitch to use its name as an expert in connection with any registration statement filed under the United States securities laws, the Financial Services and Markets Act of 2000 of the United Kingdom, or the securities laws of any particular jurisdiction. Due to the relative efficiency of electronic publishing and distribution, Fitch research may be available to electronic subscribers up to three days earlier than to print subscribers.

For Australia, New Zealand, Taiwan and South Korea only: Fitch Australia Pty Ltd holds an Australian financial services license (AFS license no. 337123) which authorizes it to provide credit ratings to wholesale clients only. Credit ratings information published by Fitch is not intended to be used by persons who are retail clients within the meaning of the Corporations Act 2001

Contacts

Fitch Ratings
Primary Analyst
Emily Wong
Senior Director
+1-415-732-5620
Fitch Ratings, Inc.
650 California Street, 4th Floor
San Francisco, CA 94108
or
Secondary Analyst
Olga Beck
Director
+1-212-908-0772
or
Committee Chairperson
James LeBuhn
Senior Director
+1-312-368-2059
or
Media Relations
Elizabeth Fogerty, +1 212-908-0526
elizabeth.fogerty@fitchratings.com

Contacts

Fitch Ratings
Primary Analyst
Emily Wong
Senior Director
+1-415-732-5620
Fitch Ratings, Inc.
650 California Street, 4th Floor
San Francisco, CA 94108
or
Secondary Analyst
Olga Beck
Director
+1-212-908-0772
or
Committee Chairperson
James LeBuhn
Senior Director
+1-312-368-2059
or
Media Relations
Elizabeth Fogerty, +1 212-908-0526
elizabeth.fogerty@fitchratings.com